Ipledge: A report from the front lines of dermatologic practice

Virtual Mentor

Volumn 8, Issue 8, 2006, Pages 524-528

  Cockerell, Clay J ^a   Thiboutot, Diane M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 83455214858     PISSN: 19377010     EISSN: None     Source Type: Journal    
DOI: 10.1001/virtualmentor.2006.8.8.pfor1-0608     Document Type: Review

References (5)

1. iPLEDGE. iPLEDGE Home Page. Available at: https://www.ipledgeprogram.com. Accessed July 24, 2006.
2. American Academy of Dermatology. Information on New Isotretinoin Program. Available at: http://www.aad.org/professionals/AdvocacyGovRelSkin/iso_information.htm. Accessed July 24, 2006.
3. Goldsmith LA, Bolognia JL, Callen JP, et al. American Academy of Dermatology Consensus Conference on the Safe and Optimal Use of Isotretinoin: summary and recommendations. J Am Acad Dermatol. 2004;50:900-906.
4. Food and Drug Administration. Isotretonoin (marketed as Accutane) Capsule Information. Available at: http://www.fda.gov/cder/drug/infopage/accutane/default.htm. Accessed July 21, 2006.
5. Food and Drug Administration. CDER 2004 Meeting Documents. Dermatologic and Ophthalmic Drugs Advisory Committee. Available at: http://www.fda.gov/ohrms/dockets/ac/cder04.html#Dermatologic. Accessed July 21, 2006.